Author:
Al-Hilli Zahraa,Noss Ryan,Dickard Jennifer,Wei Wei,Chichura Anna,Wu Vincent,Renicker Kayla,Pederson Holly J.,Eng Charis
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Genetic/familial high-risk assessment: breast, ovarian, and pancreatic. Version 3. 2023. www.NCCN.org. Accessed 11 Apr 2023.
2. Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle?. J Clin Oncol. 2019;37(6):453–60.
3. Yang S, Axilbund JE, O’Leary E, et al. Underdiagnosis of hereditary breast and ovarian cancer in medicare patients: genetic testing criteria miss the mark. Ann Surg Oncol. 2018;25(10):2925–31.
4. Consensus guideline of genetic testing for hereditary breast cancer. http://www.breastsurgeons.ord/docs/statements/Consensus-Guidelines-on-genetic-Testing-for-Hereditary-BReast-Cancer.pdf. Accessed 11 Apr 2023.
5. National Cancer Institute. Cancer Stat Fact Sheets. http://seer.cancer.gov/. Accessed 11 Apr 2023.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献